By bridging the advantages of wet and digital assays, TandemAI has become the top choice for leading drug hunters, who value TandemAI's ability to improve capital efficiency and increase the chances of successful drug discovery.

TandemAI is advancing a drug discovery platform that merges sophisticated digital assay capabilities with extensive wet lab infrastructures, with the potential to transform drug discovery across small molecules, peptides, PROTAC, and RNA. The platform integrates advanced digital assays, based on rigorous physics and state-of-the-art generative AI algorithms, with wet lab processes through an extremely user-friendly interface. This platform is designed to offer drug hunters innovative compound screening and design solutions. TandemAI has built an international infrastructure, establishing itself as the go-to partner for innovative drug hunters.